MiNK Therapeutics Stock (NASDAQ: INKT) stock price, news, charts, stock research, profile.
Open | $0.900 |
Close | $0.928 |
Volume / Avg. | 32.366K / 97.146K |
Day Range | 0.881 - 0.930 |
52 Wk Range | 0.750 - 3.340 |
Market Cap | $33.828M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 0.77% |
Days to Cover | 1.05 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MiNK Therapeutics (NASDAQ: INKT) through any online brokerage.
Other companies in MiNK Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX), Palatin Techs (AMEX:PTN) and Sensei Biotherapeutics (NASDAQ:SNSE).
The latest price target for MiNK Therapeutics (NASDAQ: INKT) was reported by HC Wainwright & Co. on Thursday, March 21, 2024. The analyst firm set a price target for 9.00 expecting INKT to rise to within 12 months (a possible 823.17% upside). 3 analyst firms have reported ratings in the last year.
The stock price for MiNK Therapeutics (NASDAQ: INKT) is $0.9749 last updated Today at April 26, 2024 at 4:36 PM EDT.
There are no upcoming dividends for MiNK Therapeutics.
MiNK Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for MiNK Therapeutics.
MiNK Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.